Turning Cancer Patients and Caregivers Into Informed Decision- Makers
Hi, my name is David Emerson, and I have been living with an incurable cancer called Multiple Myeloma since 1994. I started PeopleBeatingCancer.org because I believe that there is a problem with cancer care today. Cancer patients and caregivers are asked to make huge decisions about their health-- often while woefully uninformed, and under an extreme time crunch. How many of you are here because you were given 24 hours to approve your chemotherapy regimen?
Let me be clear: knowledge is power. The more you know, the better decisions you'll make for your care. Yes, I said YOU. You are in control. This website and the non-profit organization that supports it are dedicated to helping cancer survivors and caregivers become informed, educated decision-makers about their treatment. All information found on this site is evidence-based with the studies cited, and actionable-- you can get started using the protocols right away.
Welcome!
Check out our latest blog posts:
Hempseed and Heart Health
Recent studies, mostly in animals, have examined the effects of these fatty acids and dietary hempseed itself on platelet aggregation,[...]
A-fib- Reduce Risk of Stroke, Dementia Now-
The researchers found that people with A-fib showed a faster rate of decline in thinking and memory skills than those[...]
Curcumin Lowers Blood Pressure/Hypertension
Therefore, curcumin is considered to be a new therapeutic candidate for cardiovascular disease, including idiopathic pulmonary arterial hypertension... The article[...]
Mind-Body Give / Receive Myeloma Therapy
"Research shows why it’s physically better for us to give than receive...People who volunteer get sick less often and live longer."[...]
Chemotherapy For Multiple Myeloma: An Overview of Options and Side Effects
Every Chemotherapy Comes with Side Effects-- Short-Term, Long-Term, and Late-Stage. Integrative Therapies Can Help. Chemotherapy for multiple myeloma has changed[...]
Remission for Myeloma- QOL or PFS?
long-term use of lenalidomide significantly improves the time myeloma patients stay in remission after initial therapy. For newly diagnosed myeloma[...]